DK0981534T3 - Dinukleotider og deres anvendelser - Google Patents
Dinukleotider og deres anvendelserInfo
- Publication number
- DK0981534T3 DK0981534T3 DK98907435T DK98907435T DK0981534T3 DK 0981534 T3 DK0981534 T3 DK 0981534T3 DK 98907435 T DK98907435 T DK 98907435T DK 98907435 T DK98907435 T DK 98907435T DK 0981534 T3 DK0981534 T3 DK 0981534T3
- Authority
- DK
- Denmark
- Prior art keywords
- sub
- useful
- treatment
- well
- present
- Prior art date
Links
- 206010036790 Productive cough Diseases 0.000 abstract 2
- 206010006458 Bronchitis chronic Diseases 0.000 abstract 1
- 208000006545 Chronic Obstructive Pulmonary Disease Diseases 0.000 abstract 1
- 201000003883 Cystic fibrosis Diseases 0.000 abstract 1
- 208000003556 Dry Eye Syndromes Diseases 0.000 abstract 1
- 206010033078 Otitis media Diseases 0.000 abstract 1
- 102100037601 P2X purinoceptor 4 Human genes 0.000 abstract 1
- 206010048705 Paraneoplastic cerebellar degeneration Diseases 0.000 abstract 1
- 208000017787 Paraneoplastic neurologic syndrome Diseases 0.000 abstract 1
- 206010035664 Pneumonia Diseases 0.000 abstract 1
- 108010080192 Purinergic Receptors Proteins 0.000 abstract 1
- 206010038848 Retinal detachment Diseases 0.000 abstract 1
- 239000000556 agonist Substances 0.000 abstract 1
- 230000035559 beat frequency Effects 0.000 abstract 1
- 206010006451 bronchitis Diseases 0.000 abstract 1
- 208000007451 chronic bronchitis Diseases 0.000 abstract 1
- 230000001886 ciliary effect Effects 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 238000009472 formulation Methods 0.000 abstract 1
- 230000006698 induction Effects 0.000 abstract 1
- 208000000617 lacrimal duct obstruction Diseases 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 210000003097 mucus Anatomy 0.000 abstract 1
- 208000032307 premature centromere division Diseases 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 201000009266 primary ciliary dyskinesia Diseases 0.000 abstract 1
- 230000000717 retained effect Effects 0.000 abstract 1
- 230000004264 retinal detachment Effects 0.000 abstract 1
- 230000028327 secretion Effects 0.000 abstract 1
- 201000009890 sinusitis Diseases 0.000 abstract 1
- 210000003802 sputum Anatomy 0.000 abstract 1
- 208000024794 sputum Diseases 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/06—Pyrimidine radicals
- C07H19/10—Pyrimidine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7084—Compounds having two nucleosides or nucleotides, e.g. nicotinamide-adenine dinucleotide, flavine-adenine dinucleotide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/10—Expectorants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/16—Purine radicals
- C07H19/20—Purine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Molecular Biology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Ophthalmology & Optometry (AREA)
- Pulmonology (AREA)
- Epidemiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Cardiology (AREA)
- Otolaryngology (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/797,472 US5900407A (en) | 1997-02-06 | 1997-02-06 | Method of treating dry eye disease with uridine triphosphates and related compounds |
| US08/798,508 US5837861A (en) | 1997-02-10 | 1997-02-10 | Dinucleotides and their use as modulators of mucociliary clearance and ciliary beat frequency |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0981534T3 true DK0981534T3 (da) | 2006-09-04 |
Family
ID=27121880
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK98907435T DK0981534T3 (da) | 1997-02-06 | 1998-02-06 | Dinukleotider og deres anvendelser |
Country Status (16)
| Country | Link |
|---|---|
| US (2) | US6348589B1 (enExample) |
| EP (1) | EP0981534B1 (enExample) |
| JP (1) | JP4531867B2 (enExample) |
| KR (1) | KR100606131B1 (enExample) |
| CN (1) | CN1262556C (enExample) |
| AT (1) | ATE325129T1 (enExample) |
| AU (1) | AU738907C (enExample) |
| BR (1) | BR9807169A (enExample) |
| CA (1) | CA2279963C (enExample) |
| DE (1) | DE69834392T2 (enExample) |
| DK (1) | DK0981534T3 (enExample) |
| ES (1) | ES2264197T3 (enExample) |
| NO (1) | NO326718B1 (enExample) |
| NZ (1) | NZ337225A (enExample) |
| PT (1) | PT981534E (enExample) |
| WO (1) | WO1998034942A2 (enExample) |
Families Citing this family (67)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6673779B2 (en) * | 1996-03-27 | 2004-01-06 | Inspire Pharmaceuticals, Inc. | Method of treating ciliary dyskinesia with dinucleoside polyphosphate compounds or UTP analogues |
| US6319908B1 (en) | 1996-07-03 | 2001-11-20 | Inspire Pharmaceuticals, Inc. | Method for large-scale production of di(uridine 5′-tetraphosphate) and salts thereof |
| US5763447C1 (en) | 1996-07-23 | 2002-05-07 | Inspire Pharmaceuticals | Method of preventing or treating pneumonia in immobilized patients with uridine triphosphates and related compounds |
| DE69834392T2 (de) | 1997-02-06 | 2007-02-08 | Inspire Pharmaceuticals, Inc. | Dinukleotide und ihre verwendungen |
| US6818629B2 (en) * | 1997-02-10 | 2004-11-16 | Inspire Pharmaceuticals, Inc. | Pharmaceutical formulation comprising P1-(2'-deoxycytidine 5'-)P4-(uridine 5'-) tetraphosphate |
| US6596725B2 (en) | 1997-02-10 | 2003-07-22 | Inspire Pharmaceuticals, Inc. | Use of certain dinucleotides to stimulate removal of fluid in retinal detachment and retinal edema |
| US7223744B2 (en) * | 1997-02-10 | 2007-05-29 | Inspire Pharmaceuticals, Inc. | Pharmaceutical formulation comprising dinucleoside polyphosphates and salts thereof |
| US7078391B2 (en) * | 1997-02-10 | 2006-07-18 | Inspire Pharmaceuticals, Inc. | Method of treating edematous retinal disorders |
| US6462028B2 (en) | 1997-07-25 | 2002-10-08 | Inspire Pharmaceuticals, Inc. | Method of promoting cervical and vaginal secretions |
| US6872710B2 (en) | 1997-07-25 | 2005-03-29 | Inspire Pharmaceuticals, Inc. | Di(uridine 5′)-tetraphosphate and salts thereof |
| US6548658B2 (en) * | 1997-07-25 | 2003-04-15 | Inspire Pharmaceuticals, Inc. | Di-(uridine 5′)-tetraphosphate and salts thereof |
| EP1012154B1 (en) * | 1997-07-25 | 2004-03-17 | Inspire Pharmaceuticals, Inc. | Salts of di(uridine 5'-tetraphosphate), method for preparation and uses thereof |
| TW593331B (en) | 1997-07-25 | 2004-06-21 | Inspire Pharmaceuticals Inc | Method for large-scale production of di(uridine 5')-tetraphosphate and salts thereof |
| ATE288273T1 (de) * | 1997-08-29 | 2005-02-15 | Univ North Carolina | Verwendung von uridin-5'-diphosphat und analoge zur behandlung von lungenerkrankungen |
| WO1999061012A2 (en) * | 1998-05-22 | 1999-12-02 | Inspire Pharmaceuticals, Inc. | Therapeutic dinucleotide and derivatives |
| EP1140967A1 (en) * | 1998-12-23 | 2001-10-10 | University Of North Carolina At Chapel Hill | Targeted gene transfer using g protein coupled receptors |
| AR023088A1 (es) | 1999-02-26 | 2002-09-04 | Inspire Pharmaceuticals Inc | Uso de disfosfatos de uridina, adenina y citidina y analogos de los mismos para la manufactura de un medicamento para la estimulacion de la hidratacion delas mucosas. |
| EP1362862B1 (en) * | 1999-06-30 | 2005-07-27 | Yamasa Corporation | Dinucleotide crystals |
| WO2001012644A1 (en) * | 1999-08-17 | 2001-02-22 | Adani, Alexander | Dinucleoside 5',5'-tetraphosphates as inhibitors of viral reverse transcriptases and viruses |
| AU2603101A (en) * | 1999-12-22 | 2001-07-03 | Inspire Pharmaceuticals, Inc. | Method of treating gastrointestinal tract disease with purinergic receptor agonists |
| RU2161982C1 (ru) * | 2000-01-20 | 2001-01-20 | Общество с ограниченной ответственностью "Клиника Института биорегуляции и геронтологии" | Тетрапептид, стимулирующий функцию сетчатой оболочки глаза, фармакологическое средство на его основе и способ его применения |
| US6864243B1 (en) | 2000-05-12 | 2005-03-08 | Inspire Pharmaceuticals, Inc. | Method for treating retinal degeneration with purinergic receptor agonists |
| BR0111297A (pt) | 2000-05-30 | 2004-01-06 | Santen Pharmaceutical Co Ltd | Promotor de migração epitelial corneana |
| US6555675B2 (en) * | 2000-08-21 | 2003-04-29 | Inspire Pharmaceuticals, Inc. | Dinucleoside polyphosphate compositions and their therapuetic use as purinergic receptor agonists |
| US7115585B2 (en) * | 2000-08-21 | 2006-10-03 | Inspire Pharmaceuticals, Inc. | Compositions for treating epithelial and retinal tissue diseases |
| US6867199B2 (en) | 2000-08-21 | 2005-03-15 | Inspire Pharmaceuticals, Inc. | Dinucleoside polyphosphate compositions and their therapeutic use |
| US7452870B2 (en) * | 2000-08-21 | 2008-11-18 | Inspire Pharmaceuticals, Inc. | Drug-eluting stents coated with P2Y12 receptor antagonist compound |
| US7018985B1 (en) | 2000-08-21 | 2006-03-28 | Inspire Pharmaceuticals, Inc. | Composition and method for inhibiting platelet aggregation |
| US7132408B2 (en) * | 2000-08-21 | 2006-11-07 | Inspire Pharmaceuticals, Inc. | Composition and method for inhibiting platelet aggregation |
| BR0116221A (pt) * | 2000-12-15 | 2005-09-13 | Pharmasset Ltd | Agentes antivirais para tratamento de infecções por flaviviridae |
| EP1368366A1 (en) * | 2001-02-07 | 2003-12-10 | Celltech R & D Limited | Non-natural nucleotides and dinucleotides |
| GB2394419B (en) | 2001-06-25 | 2005-09-07 | Inspire Pharmaceuticals Inc | Joint lubrication with p2y purinergic receptor agonists |
| WO2003011885A1 (en) * | 2001-07-25 | 2003-02-13 | Celltech R & D Limited | Non-natural carbon-linked nucleotides and dinucleotides |
| WO2003030892A1 (en) * | 2001-10-11 | 2003-04-17 | Alcon, Inc. | Methods for treating dry eye |
| KR20050043761A (ko) | 2001-11-06 | 2005-05-11 | 인스파이어 파마슈티컬스 인코퍼레이티드 | 염증성 질환의 치료 또는 예방 방법 |
| US7084128B2 (en) | 2002-01-18 | 2006-08-01 | Inspire Pharmaceuticals, Inc. | Method for reducing intraocular pressure |
| CN1700894A (zh) * | 2002-10-18 | 2005-11-23 | 莫利化学医药公司 | 使用羊毛硫抗生素治疗干眼病的方法 |
| US6984628B2 (en) * | 2003-07-15 | 2006-01-10 | Allergan, Inc. | Ophthalmic compositions comprising trefoil factor family peptides |
| EP1750740A4 (en) * | 2004-05-06 | 2009-06-10 | Molichem Medicines Inc | TREATMENT OF MEMBRANE-ASSOCIATED DISEASES AND DISORDERS USING COMPOSITIONS CONTAINING LANTIBIOTICS |
| CA2565545A1 (en) * | 2004-05-06 | 2005-12-08 | Molichem Medicines, Inc. | Treatment of ocular diseases and disorders using lantibiotic compositions |
| GB0417886D0 (en) * | 2004-08-11 | 2004-09-15 | Univ Cardiff | Method and means for enhanced pulmonary delivery |
| GB0502250D0 (en) * | 2005-02-03 | 2005-03-09 | Ic Vec Ltd | Use |
| US7368439B2 (en) * | 2005-06-15 | 2008-05-06 | Bar - Ilan University | Dinucleoside poly(borano)phosphate derivatives and uses thereof |
| US7851456B2 (en) * | 2005-06-29 | 2010-12-14 | Inspire Pharmaceuticals, Inc. | P2Y6 receptor agonists for treating lung diseases |
| EP2036567A3 (en) | 2005-12-06 | 2009-12-09 | P2-Science APS | Modulation of the P2Y2 receptor pathway |
| US20070249556A1 (en) * | 2006-04-21 | 2007-10-25 | Brubaker Kurt E | Method of treating inflammation |
| WO2008012949A1 (en) * | 2006-07-26 | 2008-01-31 | Yamasa Corporation | Process for producing di(pyrimidine nucleoside 5'-)polyphosphate |
| JP2009544754A (ja) * | 2006-07-28 | 2009-12-17 | アプライド バイオシステムズ， エルエルシー | ジヌクレオチドｍｒｎａキャップアナログ |
| AU2008310734B2 (en) | 2007-10-10 | 2014-06-05 | Parion Sciences, Inc. | Delivering osmolytes by nasal cannula |
| WO2010048341A1 (en) * | 2008-10-22 | 2010-04-29 | Inspire Pharmaceuticals, Inc. | Method for treating cystic fibrosis |
| WO2010071587A1 (en) * | 2008-12-18 | 2010-06-24 | Avaris Ab | A complex and method for enhancing nuclear delivery |
| WO2012031186A1 (en) | 2010-09-03 | 2012-03-08 | Wisconsin Pharmacal Company, Llc. | Prebiotic suppositories |
| US9006208B2 (en) * | 2010-09-10 | 2015-04-14 | Santen Pharmaceutical Co., Ltd. | Agent for treatment of dry eye characterized by combining P2Y2 receptor agonist and hyaluronic acid or salt thereof, method for treating dry eye, and use of the P2Y2 receptor agonist and hyaluronic acid or salt thereof |
| US8945605B2 (en) | 2011-06-07 | 2015-02-03 | Parion Sciences, Inc. | Aerosol delivery systems, compositions and methods |
| US8778383B2 (en) | 2011-06-07 | 2014-07-15 | Parion Sciences, Inc. | Methods of treatment |
| AR086745A1 (es) | 2011-06-27 | 2014-01-22 | Parion Sciences Inc | 3,5-diamino-6-cloro-n-(n-(4-(4-(2-(hexil(2,3,4,5,6-pentahidroxihexil)amino)etoxi)fenil)butil)carbamimidoil)pirazina-2-carboxamida |
| KR20190002751A (ko) | 2012-03-26 | 2019-01-08 | 산텐 세이야꾸 가부시키가이샤 | 디쿠아포솔 함유 점안액 |
| SI2855435T1 (sl) | 2012-05-29 | 2018-09-28 | Parion Sciences Inc. | Dendrimeru podobni amino amidi, ki imajo delovanje blokatorja natrijevih kanalov za zdravljenje suhih oči in drugih mukoznih bolezni |
| SI2931713T1 (sl) | 2012-12-17 | 2017-03-31 | Parion Sciences, Inc. | Derivati kloro-pirazin karboksamida uporabni za zdravljenje bolezni favoriziranih z nezadostno hidracijo sluznice |
| CA2896686A1 (en) | 2012-12-17 | 2014-06-26 | Parion Sciences, Inc. | 3,5-diamino-6-chloro-n-(n-(4-phenylbutyl)carbamimidoyl) pyrazine-2- carboxamide compounds |
| EP2931712B8 (en) | 2012-12-17 | 2018-05-23 | Parion Sciences, Inc. | 3,5-diamino-6-chloro-n-(n-(4-phenylbutyl)carbamimidoyl) pyrazine-2- carboxamide compounds |
| EP3174891B1 (en) | 2014-07-24 | 2020-01-29 | W.R. Grace & CO. - CONN. | Crystalline form of nicotinamide riboside |
| BR112017019409A2 (pt) | 2015-03-09 | 2018-04-24 | Grace W R & Co | forma cristalina de ribosídeo de nicotinamida |
| EP3297615A1 (en) | 2015-05-20 | 2018-03-28 | INSERM - Institut National de la Santé et de la Recherche Médicale | Methods and pharmaceutical composition for modulation polarization and activation of macrophages |
| CN112020363A (zh) | 2017-12-22 | 2020-12-01 | 益力舒健康公司 | 烟酰胺核苷氯化物的结晶形式 |
| EP3919062A1 (en) | 2020-06-02 | 2021-12-08 | Institut Gustave-Roussy | Modulators of purinergic receptors and related immune checkpoint for treating acute respiratory distress syndrom |
| EP4157288A2 (en) | 2020-06-02 | 2023-04-05 | Institut Gustave-Roussy | Modulators of purinergic receptors and related immune checkpoint for treating acute respiratory distress syndrom |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4855304A (en) | 1985-01-10 | 1989-08-08 | Repligen Corporation | Dinucleoside pyrophosphates and pyrophosphate homologs as plant antivirals |
| US5049550A (en) * | 1987-11-05 | 1991-09-17 | Worcester Foundation For Experimental Biology | Diadenosine 5', 5'"-p1, p4,-tetraphosphate analogs as antithrombotic agents |
| US5292498A (en) | 1991-06-19 | 1994-03-08 | The University Of North Carolina At Chapel Hill | Method of treating lung disease with uridine triphosphates |
| FI970081A7 (fi) * | 1994-07-15 | 1997-01-08 | Biosearch Italia Spa | Dinukleosidi-5',5'-pyrofosfaatit |
| US5635160A (en) * | 1995-06-07 | 1997-06-03 | The University Of North Carolina At Chapel Hill | Dinucleotides useful for the treatment of cystic fibrosis and for hydrating mucus secretions |
| US5837861A (en) * | 1997-02-10 | 1998-11-17 | Inspire Pharmaceuticals, Inc. | Dinucleotides and their use as modulators of mucociliary clearance and ciliary beat frequency |
| US5681823A (en) * | 1996-05-02 | 1997-10-28 | Prp Inc. | P1, P4 -dithio-P2 -P3 -monochloromethylene 5', 5'"-diadenosine P1, P4 -tetraphosphate as antithrombotic agent |
| US5789391A (en) | 1996-07-03 | 1998-08-04 | Inspire Pharmaceuticals, Inc. | Method of treating sinusitis with uridine triphosphates and related compounds |
| US5763447C1 (en) * | 1996-07-23 | 2002-05-07 | Inspire Pharmaceuticals | Method of preventing or treating pneumonia in immobilized patients with uridine triphosphates and related compounds |
| PT934325E (pt) * | 1996-10-09 | 2004-10-29 | Pharmasset Ltd | Trisanidridos biciclicos de tetrafosfonato |
| DE69834392T2 (de) | 1997-02-06 | 2007-02-08 | Inspire Pharmaceuticals, Inc. | Dinukleotide und ihre verwendungen |
-
1998
- 1998-02-06 DE DE69834392T patent/DE69834392T2/de not_active Expired - Lifetime
- 1998-02-06 AU AU63242/98A patent/AU738907C/en not_active Ceased
- 1998-02-06 EP EP98907435A patent/EP0981534B1/en not_active Expired - Lifetime
- 1998-02-06 BR BR9807169-6A patent/BR9807169A/pt active Search and Examination
- 1998-02-06 JP JP53505598A patent/JP4531867B2/ja not_active Expired - Fee Related
- 1998-02-06 NZ NZ337225A patent/NZ337225A/en not_active IP Right Cessation
- 1998-02-06 US US09/101,395 patent/US6348589B1/en not_active Expired - Lifetime
- 1998-02-06 KR KR1019997007070A patent/KR100606131B1/ko not_active Expired - Fee Related
- 1998-02-06 DK DK98907435T patent/DK0981534T3/da active
- 1998-02-06 PT PT98907435T patent/PT981534E/pt unknown
- 1998-02-06 CA CA002279963A patent/CA2279963C/en not_active Expired - Fee Related
- 1998-02-06 ES ES98907435T patent/ES2264197T3/es not_active Expired - Lifetime
- 1998-02-06 AT AT98907435T patent/ATE325129T1/de active
- 1998-02-06 CN CNB988032597A patent/CN1262556C/zh not_active Expired - Fee Related
- 1998-02-06 WO PCT/US1998/002702 patent/WO1998034942A2/en not_active Ceased
-
1999
- 1999-08-04 NO NO19993776A patent/NO326718B1/no not_active IP Right Cessation
-
2001
- 2001-11-06 US US10/007,451 patent/US6977246B2/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| NO993776D0 (no) | 1999-08-04 |
| NO326718B1 (no) | 2009-02-02 |
| CA2279963A1 (en) | 1998-08-13 |
| AU738907B2 (en) | 2001-09-27 |
| US6977246B2 (en) | 2005-12-20 |
| ES2264197T3 (es) | 2006-12-16 |
| WO1998034942A3 (en) | 2000-01-06 |
| JP4531867B2 (ja) | 2010-08-25 |
| PT981534E (pt) | 2006-09-29 |
| AU738907C (en) | 2002-05-16 |
| EP0981534A2 (en) | 2000-03-01 |
| JP2001526635A (ja) | 2001-12-18 |
| DE69834392D1 (de) | 2006-06-08 |
| BR9807169A (pt) | 2000-06-06 |
| WO1998034942A2 (en) | 1998-08-13 |
| CA2279963C (en) | 2008-04-22 |
| KR20000070807A (ko) | 2000-11-25 |
| US20020082417A1 (en) | 2002-06-27 |
| KR100606131B1 (ko) | 2006-07-31 |
| EP0981534B1 (en) | 2006-05-03 |
| NO993776L (no) | 1999-10-06 |
| CN1262556C (zh) | 2006-07-05 |
| CN1292795A (zh) | 2001-04-25 |
| US6348589B1 (en) | 2002-02-19 |
| NZ337225A (en) | 2002-03-28 |
| ATE325129T1 (de) | 2006-06-15 |
| AU6324298A (en) | 1998-08-26 |
| DE69834392T2 (de) | 2007-02-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK0981534T3 (da) | Dinukleotider og deres anvendelser | |
| WO1999061012A3 (en) | Therapeutic dinucleotide and derivatives | |
| AR011127A1 (es) | COMPUESTOS DINUCLEoTIDOS, COMPOSICIoN FARMACÉUTICA QUE LOS CONTIENE Y SU USO PARA PREPARAR UN MEDICAMENTO | |
| JP2002516273A5 (enExample) | ||
| SG146649A1 (en) | Mucoactive agents for treating a pulmonary disease | |
| IS6444A (is) | Pýrimidín karboxamíð nytsamleg sem latar á PDE4 samsætuensím | |
| WO2002020722A3 (en) | Methods and compositions for in vitro targeting | |
| DE69937198D1 (de) | Behandlung der alzheimer-krankheit durch erhöhung des cytidin-spiegels in vivo | |
| MXPA02011311A (es) | Composicion novedosa. | |
| US6555675B2 (en) | Dinucleoside polyphosphate compositions and their therapuetic use as purinergic receptor agonists | |
| MXPA04000162A (es) | Metodos para incrementar la eficacia in vivo de oligonucleotidos e inhibir la inflamacion en mamiferos. | |
| WO2002070532A3 (en) | C2,5'-disubstituted and n6,c2,5'-trisubstituted adenosine derivatives and their different uses | |
| WO2002083167A3 (en) | Therapeutic compositions for the treatment of a respiratory tract disease | |
| US6867199B2 (en) | Dinucleoside polyphosphate compositions and their therapeutic use | |
| AU4335901A (en) | Novel therapeutic treatment of chronic obstructive pulmonary disease | |
| WO2003037309A3 (en) | USE OF 4α PHORBOL | |
| IT1281501B1 (it) | Impiego di combinazioni di analoghi di nucleosidi nella terapia delle infezioni da virus dell'aids | |
| AU2001243359A1 (en) | Novel therapeutic treatment of chronic obstructive pulmonary disease | |
| AU2001251400A1 (en) | Treatment of pulmonary disorders by inducing alveoli formation |